Syngo.Mr Onco, Syngo.Mr 3D Lesion Segmentation, Syngo.Mr Onco Engine

FDA 510(k) K111861 · Siemens Medical Systems USA

Substantially Equivalent

510(k) numberK111861

Submission

Device name
Syngo.Mr Onco, Syngo.Mr 3D Lesion Segmentation, Syngo.Mr Onco Engine
Applicant
Siemens Medical Systems USA
Malvern, PA, US
Received
June 30, 2011
Decision date
January 6, 2012
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LLZ – System, Image Processing, Radiological
Device class
Class II (moderate risk)
Regulation
21 CFR 892.2050
Specialty
Radiology

Other 510(k)s with product code LLZ

510(k)DeviceApplicantDecision
K2620603D-RD-SLLZ · Traditional Radiopharmaceutical Imaging & Dosimetry, LLC09/04/2026SE
K261500KBA3D (v2.4.0)LLZ · Traditional S.M.A.I.O08/17/2026SE
K262449AdvaViewLLZ · Special Advahealth Solutions, LLC08/14/2026SE
K261916NeuroQuant PETLLZ · Traditional Cortechs Labs, Inc.08/12/2026SE
K260936RadioViewAILLZ · Traditional Neurocareai, Inc. (Dba Savelife.Ai)07/31/2026SE
K260588Cleerly LABSLLZ · Traditional Cleerly, Inc.07/29/2026SE
K262462TheraSphere 360™ Y-90 Management PlatformLLZ · Special Boston Scientific Corporation07/24/2026SE
K262143ImageGrid StreamVueLLZ · Traditional Candelis, Inc.07/23/2026SE
K260500ResolutionMDLLZ · Traditional ResolutionMD, Inc.07/21/2026SE
K262120Avara ViewerLLZ · Traditional Avara Software07/10/2026SE

More from Avara Software

510(k)DeviceDecision
K210054Cios SpinOWB · Special 02/05/2021SE
K181560Cios AlphaOWB · Traditional 10/24/2018SE

Questions and answers

When was Syngo.Mr Onco, Syngo.Mr 3D Lesion Segmentation, Syngo.Mr Onco Engine cleared by the FDA?

Syngo.Mr Onco, Syngo.Mr 3D Lesion Segmentation, Syngo.Mr Onco Engine (K111861) received a 510(k) decision of Substantially Equivalent on January 6, 2012, 190 days after the submission was received.

What is the product code of K111861?

The FDA product code is LLZ – System, Image Processing, Radiological, a Class II (moderate risk) device regulated under 21 CFR 892.2050.